Distinct immune trajectories in patients with chromosome 22q11.2 deletion syndrome and immune-mediated diseases

Identification of biomarkers associated with immune-mediated diseases in 22q11.2 deletion syndrome is an evolving field. We sought to use a carefully phenotyped cohort to study immune parameters associated with autoimmunity and atopy in 22q11.2 deletion syndrome to define biomarkers associated with...

Full description

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 149; no. 1; pp. 445 - 450
Main Authors Crowley, T. Blaine, Campbell, Ian M., Liebling, Emily J., Lambert, Michele P., Levitt Katz, Lorraine E., Heimall, Jennifer, Bailey, Alice, McGinn, Daniel E., McDonald McGinn, Donna M., Sullivan, Kathleen E.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.01.2022
Subjects
Online AccessGet full text
ISSN0091-6749
1097-6825
1097-6825
DOI10.1016/j.jaci.2021.06.007

Cover

More Information
Summary:Identification of biomarkers associated with immune-mediated diseases in 22q11.2 deletion syndrome is an evolving field. We sought to use a carefully phenotyped cohort to study immune parameters associated with autoimmunity and atopy in 22q11.2 deletion syndrome to define biomarkers associated with immune-mediated disease in this syndrome. Chart review validated autoimmune disease and atopic condition diagnoses. Laboratory data were extracted for each subcohort and plotted according to age. A random-effects model was used to define statistical significance. CD19, CD4, and CD4/45RA lymphocyte populations were not different from the general cohort for patients with atopic conditions. CD4/45RA T cells were significantly lower in the subjects with immune thrombocytopenia compared with the general cohort, and CD4 T-cell counts were lower in patients with autoimmune thyroid disease. The mechanisms of autoimmunity in cytopenias may be distinct from those of solid-organ autoimmunity in 22q11.2 deletion syndrome. This study identifies potential biomarkers for risk stratification among commonly obtained laboratory studies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0091-6749
1097-6825
1097-6825
DOI:10.1016/j.jaci.2021.06.007